Literature DB >> 1854618

c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis.

S M Bell1, S A Kelly, J A Hoyle, F A Lewis, G R Taylor, H Thompson, M F Dixon, P Quirke.   

Abstract

One hundred and nine samples comprising carcinomas, adenomas, dysplastic, inflamed and normal mucosa from patients with sporadic colon cancer and ulcerative colitis (UC) were analysed for c-Ki-ras mutations. DNA was extracted from archival paraffin-embedded material, amplified using the polymerase chain reaction (PCR) and the PCR products analysed using restriction enzyme digestion. Forty-two per cent (14/33) of the sporadic carcinoma controls contained Ki-ras codon 12 mutations in contrast to 24% (8/33) of ulcerative colitis carcinomas. A significantly higher c-Ki-ras mutation rate was observed in rectal carcinomas (72%) in comparison to colonic carcinomas (28%) in control patients (P less than 0.04), while the opposite was observed in UC patients. The difference between the incidence of c-Ki-ras mutations in rectal carcinomas in UC (9%) and in sporadic rectal carcinomas (72%) was also significant (P less than 0.01). This lower prevalence rate and different site distribution of c-Ki-ras mutations in UC carcinomas compared to sporadic carcinomas suggests that specific genetic differences may underlie the causation of carcinomas arising in these situations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1854618      PMCID: PMC1977292          DOI: 10.1038/bjc.1991.264

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

1.  ABO blood group distribution in ulcerative and malignant diseases of the gastrointestinal tract; incidence in three communal groups in Israel.

Authors:  D BIRNBAUM; J MENCZEL
Journal:  Gastroenterology       Date:  1959-08       Impact factor: 22.682

Review 2.  Screening for colorectal cancer in ulcerative colitis: dubious benefits and high costs.

Authors:  S Gyde
Journal:  Gut       Date:  1990-10       Impact factor: 23.059

3.  "Precancer" lesions in ulcerative colits. A retrospective study of rectal biopsy and colectomy specimens.

Authors:  J H Yardley; D F Keren
Journal:  Cancer       Date:  1974-09       Impact factor: 6.860

4.  Lectin and mucin histochemistry as an aid to cancer surveillance in ulcerative colitis.

Authors:  J B Fozard; M F Dixon; A T Axon; G R Giles
Journal:  Histopathology       Date:  1987-04       Impact factor: 5.087

5.  Cancer in universal and left-sided ulcerative colitis: clinical and pathologic features.

Authors:  A J Greenstein; D B Sachar; A Pucillo; G Vassiliades; H Smith; I Kreel; S A Geller; H D Janowitz; A H Aufses
Journal:  Mt Sinai J Med       Date:  1979 Jan-Feb

Review 6.  The precarcinomatous phase of ulcerative colitis.

Authors:  R H Riddell
Journal:  Curr Top Pathol       Date:  1976

7.  Multiple genetic alterations in distal and proximal colorectal cancer.

Authors:  O Delattre; S Olschwang; D J Law; T Melot; Y Remvikos; R J Salmon; X Sastre; P Validire; A P Feinberg; G Thomas
Journal:  Lancet       Date:  1989-08-12       Impact factor: 79.321

8.  Plasma peptide YY (PYY) in dumping syndrome.

Authors:  T E Adrian; R G Long; H S Fuessl; S R Bloom
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

9.  Carcinoma of the colon and rectum complicating chronic ulcerative colitis.

Authors:  J A van Heerden; R W Beart
Journal:  Dis Colon Rectum       Date:  1980-04       Impact factor: 4.585

10.  p53 in colorectal cancer: clinicopathological correlation and prognostic significance.

Authors:  N Scott; P Sagar; J Stewart; G E Blair; M F Dixon; P Quirke
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

View more
  29 in total

1.  Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers.

Authors:  M Ilyas; I P Tomlinson; A Hanby; I C Talbot; W F Bodmer
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

2.  Bcl-2 expression in colorectal tumors: evidence of different pathways in sporadic and ulcerative-colitis-associated carcinomas.

Authors:  M Ilyas; I P Tomlinson; A M Hanby; T Yao; W F Bodmer; I C Talbot
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 3.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

Review 4.  Molecular biology of colorectal neoplasia.

Authors:  N Scott; P Quirke
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

5.  Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.

Authors:  J Young; L A Simms; K G Biden; C Wynter; V Whitehall; R Karamatic; J George; J Goldblatt; I Walpole; S A Robin; M M Borten; R Stitz; J Searle; D McKeone; L Fraser; D R Purdie; K Podger; R Price; R Buttenshaw; M D Walsh; M Barker; B A Leggett; J R Jass
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

6.  Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium.

Authors:  S Fujii; T Fujimori; H Kawamata; J Takeda; K Kitajima; F Omotehara; T Kaihara; T Kusaka; K Ichikawa; Y Ohkura; Y Ono; J Imura; S Yamaoka; C Sakamoto; Y Ueda; T Chiba
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

7.  K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.

Authors:  P Chaubert; J Benhattar; E Saraga; J Costa
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

8.  Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.

Authors:  J B Kisiel; T C Yab; F T Nazer Hussain; W R Taylor; M M Garrity-Park; W J Sandborn; E V Loftus; B G Wolff; T C Smyrk; S H Itzkowitz; D T Rubin; H Zou; D W Mahoney; D A Ahlquist
Journal:  Aliment Pharmacol Ther       Date:  2013-01-24       Impact factor: 8.171

9.  Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis.

Authors:  C A Cartwright; C A Coad; B M Egbert
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

10.  High frequency of K-ras mutations in sporadic colorectal adenomas.

Authors:  E A McLellan; R A Owen; K A Stepniewska; J P Sheffield; N R Lemoine
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.